Claro Advisors Inc.
Source: SEC Form 13F · as of Mar 2026Claro Advisors Inc. holds 27 biotech & pharma companies tracked by BioSniper, totaling $30.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$30.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 22,592 | $5.5M |
| ABBVAbbVie Inc. | 23,390 | $5.1M |
| LLYELI LILLY & Co | 3,768 | $3.5M |
| MCKMcKesson Corporation | 2,404 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 25,092 | $1.5M |
| MRKMerck & Co., Inc. | 11,638 | $1.4M |
| PFEPFIZER INC | 46,859 | $1.3M |
| AMGNAMGEN INC | 3,557 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,051 | $1.1M |
| PMPhilip Morris International Inc | 5,269 | $871K |
| NVONovo Nordisk A/S | 23,201 | $853K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,606 | $717K |
| GILDGILEAD SCIENCES, INC. | 4,194 | $585K |
| CORCencora Inc. | 1,791 | $563K |
| CAHCardinal Health Inc. | 2,590 | $547K |
| GMOptec International, Inc. | 6,247 | $465K |
| ABTABBOTT LABORATORIES | 4,445 | $456K |
| REGNREGENERON PHARMACEUTICALS, INC. | 568 | $439K |
| UTHRUNITED THERAPEUTICS Corp | 716 | $425K |
| INCYIncyte Corp. | 4,153 | $391K |
| NVSNovartis AG | 2,291 | $350K |
| IDXXIDEXX LABORATORIES INC /DE | 498 | $280K |
| ELVElevance Health Inc. | 908 | $266K |
| AZNASTRAZENECA PLC | 1,204 | $238K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,572 | $231K |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 4,275 | $221K |
| AUTLAutolus Therapeutics plc | 12,500 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.